A new class of selective GSK3B-inhibitors for refractory lymphoid malignancies
Harnessing p53beta as a medical treatment of skin cancer
First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indications
CAR-mast Cell Therapy for Solid Tumors
curIOS Therapeutics: mRNA therapies targeting the driver antigens in virus-associated cancers
Innovative approach to treat ALS using a novel small molecule target
Small molecule and enzymatic approaches to revert aberrant phase transitions in neurological disorders
Advancing a non-hallucinogenic psychedelic drug combination
